News

Abbott India Limited will hold a board meeting on Thursday, November 5, 2026, to consider and approve the unaudited financial results for the second quarter and half year ended September 30, 2026, according to a regulatory filing with the BSE Limited. The company’s trading window will remain closed from Thursday, October 1, 2026, to Saturday, November 7, 2026, in accordance with insider trading regulations.

Abbott India Limited submitted a certificate to the BSE Limited on October 6, 2026, confirming compliance with Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026, and KFin Technologies Limited acted as the Registrar and Transfer Agent for the company.

Abbott India Limited informed the BSE Limited that the trading window for dealing in the company`s shares by designated persons and their immediate relatives will be closed from Thursday, October 1, 2026, and will reopen 48 hours after the declaration of the un-audited financial results for the quarter ending September 30, 2026.

Abbott India will hold a meeting of the Board of Directors of the Company on 12 August 2026.

Abbott India announced that the 82th Annual General Meeting(AGM) of the company will be held on 13 August 2026.